Amiodarone Cost Effectiveness in Preventing Atrial Fibrillation After Coronary Artery Bypass Graft Surgery

Annals of Thoracic Surgery

Volumn 85, Issue 1, 2008, Pages 28-32

  Zebis, Lars R ^a   Christensen, Thomas D ^a   Kristiansen, Ivar S ^b,c   Hjortdal, Vibeke E ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; GLUCOSE; PLACEBO;

ADULT; AGED; AQUEOUS SOLUTION; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; COST EFFECTIVENESS ANALYSIS; DENMARK; DOUBLE BLIND PROCEDURE; EVENING DOSAGE; FEMALE; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AMIODARONE; ANALYSIS OF VARIANCE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CORONARY ARTERY BYPASS; CORONARY DISEASE; COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SURVIVAL RATE;

EID: 37249048179     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.07.060     Document Type: Article

References (26)

1. Ommen S.R., Odell J.A., and Stanton M.S. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 336 (1997) 1429-1434
2. Maisel W.H., Rawn J.D., and Stevenson W.G. Atrial fibrillation after cardiac surgery. Ann Intern Med 135 (2001) 1061-1073
3. Guarnieri T. Intravenous antiarrhythmic regimens with focus on amiodarone for prophylaxis of atrial fibrillation after open heart surgery. Am J Cardiol 84 (1999) 152R-155R
4. Samuels L.E., Holmes E.C., and Samuels F.L. Selective use of amiodarone and early cardioversion for postoperative atrial fibrillation. Ann Thorac Surg 79 (2005) 113-116
5. Yagdi T., Nalbantgil S., Ayik F., et al. Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 1420-1425
6. Redle J.D., Khurana S., Marzan R., et al. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J 138 (1999) 144-150
7. Aranki S.F., Shaw D.P., Adams D.H., et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 94 (1996) 390-397
8. Mathew J.P., Parks R., Savino J.S., et al., MultiCenter Study of Perioperative Ischemia Research Group. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. JAMA 276 (1996) 300-306
9. Seguin P., Signouret T., Laviolle B., et al. Incidence and risk factors of atrial fibrillation in a surgical intensive care unit. Crit Care Med 32 (2004) 722-726
10. Humphries J.O. Unexpected instant death following successful coronary artery bypass graft surgery (and other clinical settings): atrial fibrillation, quinidine, procainamide, et cetera, and instant death. Clin Cardiol 21 (1998) 711-718
11. Perkerson K.A., Gillespie E.L., White C.M., et al. Impact of prophylactic amiodarone on length of hospital stay, stroke, and atrial fibrillation after cardiothoracic surgery. Pharmacotherapy 25 (2005) 320-324
12. Sander S., and White C.M. The use of prophylactic amiodarone after cardiothoracic surgery reduces the incidence of atrial fibrillation. Conn Med 69 (2005) 91-94
13. Crystal E., Garfinkle M.S., Connolly S.S., et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev 4 (2004) CD003611
14. Zebis L.R., Christensen T.D., Thomsen H.F., et al. Practical regimen for amiodarone use in preventing postoperative atrial fibrillation. Ann Thorac Surg 83 (2007) 1326-1331
15. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8 (2006) 651-745
16. DiDomenico R.J., and Massad M.G. Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery. Ann Thorac Surg 79 (2005) 728-740
17. Moher D., Schulz K.F., and Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285 (2001) 1987-1991
18. Bagshaw S.M., Galbraith P.D., Mitchell L.B., et al. Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. Ann Thorac Surg 82 (2006) 1927-1937
19. Gillespie E.L., Coleman C.I., Sander S., et al. Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis. Ann Pharmacother 39 (2005) 1409-1415
20. Gillespie E.L., White C.M., Kluger J., et al. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery. Pharmacotherapy 26 (2006) 499-504
21. Budeus M., Hennersdorf M., Perings S., et al. Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study. Eur Heart J 27 (2006) 1584-1591
22. Lumer G.B., Roy D., Talajic M., et al. Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial. Eur Heart J 23 (2002) 1050-1056
23. Reddy P., Dunn A.B., White C.M., et al. An economic analysis of amiodarone versus placebo for the prevention of atrial fibrillation after open heart surgery. Pharmacotherapy 22 (2002) 75-80
24. Kerstein J., Soodan A., Qamar M., et al. Giving IV and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study. Chest 126 (2004) 716-724
25. Kim M.H., Rachwal W., McHale C., et al. Effect of amiodarone +/- diltiazem +/- beta blocker on frequency of atrial fibrillation, length of hospitalization, and hospital costs after coronary artery bypass grafting. Am J Cardiol 89 (2002) 1126-1128
26. Treggiari-Venzi M.M., Waeber J.L., Perneger T.V., et al. Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. Br J Anaesth 85 (2000) 690-695